A quality-adjusted life year (QALY) is a unit used in health economics that combines how long a person lives with how well they live. Each year of life is weighted by a quality score between 0, equivalent to death, and 1, full health, so that . Four years at a weight of 0.75 give 3 QALYs. The weights come from surveys rating states of health. Health technology assessment bodies, such as England's National Institute for Health and Care Excellence, compare treatments by their cost per QALY gained, a form of cost-benefit analysis in which future years are reduced by a discount rate.
For investors in drug makers and genomics firms, cost-per-QALY judgements influence whether a new medicine is reimbursed and at what price, and so affect expected revenue. Critics say the measure can undervalue treatments for older or disabled people, and its use is restricted in some US federal programmes. It rests on the economic idea of utility.